141 related articles for article (PubMed ID: 34623216)
1. Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study.
Bobjer J; Hagberg O; Aljabery F; Gårdmark T; Jahnson S; Jerlström T; Sherif A; Simoulis A; Ströck V; Häggström C; Holmberg L; Liedberg F
Scand J Urol; 2022 Feb; 56(1):14-18. PubMed ID: 34623216
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.
Maxwell JP; Wang C; Wiebe N; Yilmaz A; Trpkov K
Diagn Pathol; 2015 Mar; 10():3. PubMed ID: 25886613
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP).
Jones TD; Cheng L
Histopathology; 2020 Oct; 77(4):525-535. PubMed ID: 32562556
[TBL] [Abstract][Full Text] [Related]
4. The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.
Chen Z; Ding W; Xu K; Tan J; Sun C; Gou Y; Tong S; Xia G; Fang Z; Ding Q
PLoS One; 2012; 7(10):e47199. PubMed ID: 23082147
[TBL] [Abstract][Full Text] [Related]
5. CLINICO-PATHOLOGICAL PATTERN, CLASSIFICATION AND STAGING OF URINARY BLADDER CARCINOMAS--A FIVE YEARS EXPERIENCE AT A TERTIARY CARE HOSPITAL IN CENTRAL PUNJAB.
Naeem A; Naseem N; Anwar S; Butt S; Nagi AH
J Ayub Med Coll Abbottabad; 2015; 27(1):131-4. PubMed ID: 26182758
[TBL] [Abstract][Full Text] [Related]
6. The Association of A Number of Predictive Factors for The Recurrence of Papillary Urothelial Neoplasm of Low Malignant Potential: Prognostic Analysis From Multiple Academic Centers.
Kim KH; Lee SH; Kim SI; Chung BH; Koo KC; Cho JS; Bang WJ; Park JY; Hong SJ
Urol J; 2019 Dec; 16(6):558-562. PubMed ID: 30882164
[TBL] [Abstract][Full Text] [Related]
7. Bladder papillary urothelial neoplasm of low malignant potential in Chinese: a clinical and pathological analysis.
Zhang XK; Wang YY; Chen JW; Qin T
Int J Clin Exp Pathol; 2015; 8(5):5549-55. PubMed ID: 26191263
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
[TBL] [Abstract][Full Text] [Related]
9. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.
Campbell PA; Conrad RJ; Campbell CM; Nicol DL; MacTaggart P
BJU Int; 2004 Jun; 93(9):1228-31. PubMed ID: 15180612
[TBL] [Abstract][Full Text] [Related]
10. Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC).
Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
J Cancer; 2017; 8(15):2885-2891. PubMed ID: 28928878
[No Abstract] [Full Text] [Related]
11. Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential.
Fujii Y; Kawakami S; Koga F; Nemoto T; Kihara K
BJU Int; 2003 Oct; 92(6):559-62. PubMed ID: 14511033
[TBL] [Abstract][Full Text] [Related]
12. Bladder cancer: clinical and pathological profile.
Lopez-Beltran A
Scand J Urol Nephrol Suppl; 2008 Sep; (218):95-109. PubMed ID: 18815924
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.
Jones TD; Cheng L
Urol Oncol; 2021 May; 39(5):286-290. PubMed ID: 35550107
[TBL] [Abstract][Full Text] [Related]
14. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
[TBL] [Abstract][Full Text] [Related]
16. Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Hentschel AE; van Rhijn BWG; Bründl J; Compérat EM; Plass K; Rodríguez O; Henríquez JDS; Hernández V; de la Peña E; Alemany I; Turturica D; Pisano F; Soria F; Čapoun O; Bauerová L; Pešl M; Bruins HM; Runneboom W; Herdegen S; Breyer J; Brisuda A; Scavarda-Lamberti A; Calatrava A; Rubio-Briones J; Seles M; Mannweiler S; Bosschieter J; Kusuma VRM; Ashabere D; Huebner N; Cotte J; Mertens LS; Cohen D; Lunelli L; Cussenot O; Sheikh SE; Volanis D; Coté JF; Rouprêt M; Haitel A; Shariat SF; Mostafid AH; Nieuwenhuijzen JA; Zigeuner R; Dominguez-Escrig JL; Hacek J; Zlotta AR; Burger M; Evert M; Hulsbergen-van de Kaa CA; van der Heijden AG; Kiemeney LALM; Soukup V; Molinaro L; Gontero P; Llorente C; Algaba F; Palou J; N'Dow J; Babjuk M; van der Kwast TH; Sylvester RJ
Urol Oncol; 2020 May; 38(5):440-448. PubMed ID: 31704141
[TBL] [Abstract][Full Text] [Related]
17. Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study.
Liedberg F; Hagberg O; Holmäng S; Hosseini Aliabad A; Jancke G; Ljungberg B; Malmström PU; Åberg H; Jahnson S
Scand J Urol; 2015; 49(4):290-5. PubMed ID: 25624049
[TBL] [Abstract][Full Text] [Related]
18. Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.
Wang CC; Huang CY; Jhuang YL; Chen CC; Jeng YM
Histopathology; 2018 Apr; 72(5):795-803. PubMed ID: 29193225
[TBL] [Abstract][Full Text] [Related]
19. Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle-invasive bladder cancer in a multisite, community-based cohort.
Garg T; McMullen CK; Leo MC; O'Keeffe-Rosetti MC; Weinmann S; Nielsen ME
Cancer; 2021 Feb; 127(4):520-527. PubMed ID: 33146913
[TBL] [Abstract][Full Text] [Related]
20. T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
Beijert IJ; Hentschel AE; Bründl J; Compérat EM; Plass K; Rodríguez O; Subiela Henríquez JD; Hernández V; de la Peña E; Alemany I; Turturica D; Pisano F; Soria F; Čapoun O; Bauerová L; Pešl M; Maxim Bruins H; Runneboom W; Herdegen S; Breyer J; Brisuda A; Calatrava A; Rubio-Briones J; Seles M; Mannweiler S; Bosschieter J; Kusuma VRM; Ashabere D; Huebner N; Cotte J; Mertens LS; Masson-Lecomte A; Liedberg F; Cohen D; Lunelli L; Cussenot O; El Sheikh S; Volanis D; Côté JF; Rouprêt M; Haitel A; Shariat SF; Mostafid AH; Nieuwenhuijzen JA; Zigeuner R; Dominguez-Escrig JL; Hacek J; Zlotta AR; Burger M; Evert M; Hulsbergen-van de Kaa CA; van der Heijden AG; A L M Kiemeney L; Soukup V; Molinaro L; Gontero P; Llorente C; Algaba F; Palou J; N'Dow J; Ribal MJ; van der Kwast TH; Babjuk M; Sylvester RJ; van Rhijn BWG
Eur Urol Focus; 2022 Nov; 8(6):1627-1634. PubMed ID: 35577750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
